MRI Insider

Dear MRI Insider,

MRI is considered the best tool for screening and diagnosing breast cancer. But high levels of background parenchymal enhancement (BPE) -- that is, the enhancement of normal fibroglandular tissue on contrast-enhanced dynamic breast MRI -- can negatively impact the modality's performance.

In this edition's Insider Exclusive, we're highlighting results from a study that confirmed that high levels of BPE reduce cancer detection rates and sensitivity of breast MRI. But a team from Memorial Sloan Kettering Cancer Center in New York City also found that there's a particular protocol that appears to mitigate these effects.

When you've read our exclusive, check out more of our MRI coverage from the past month, including the following:

Finally, take a look at an MRI scan that made it into the journal Radiology's top images of 2022 for its depiction of myocarditis after COVID-19 vaccination in a 15-year-old boy's heart.

As 2022 comes to a close, we thank you for keeping up with MRI's many benefits through our MRI Community, and wish you all the best in the coming year.

Page 1 of 602
Next Page